Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Cancer"
DOI: 10.1038/s41416-019-0519-1
Abstract: BackgroundIdentification of biomarkers associated with benefit of adjuvant chemotherapy in stage II/III colon cancer is an important task.MethodsVessel density (VD) and tumour stroma were analysed in a randomised-trial-derived discovery cohort (n = 312) and in a stage… read more here.
Keywords: stage iii; stroma normalised; iii colon; stroma ... See more keywords